TY - JOUR
T1 - Fasting hyperglycemia in non-insulin-dependent diabetes mellitus
T2 - Contributions of excessive hepatic glucose production and impaired tissue glucose uptake
AU - DeFronzo, Ralph A.
AU - Ferrannini, Eleuterio
AU - Simonson, Donald C.
N1 - Funding Information:
From the Division of Diabetes/Endocrinology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT. Supported by NIH Grant Nos. AM 24092 and AGO0233 and Clinical Research Center Grant No. RR1 25. Address reprint requests to Ralph A. DeFronzo. Chief. MD, Diabetes Division, Department of Medicine, University of Texas Health Science Center. 7703 Floyd Curl Dr. San Antonio, TX 78284. o 1989 by Grune & Stratton, Inc. 0026-0495/s9/3804-0017$03.00/0
PY - 1989/4
Y1 - 1989/4
N2 - The factors responsible for fasting hyperglycemia were investigated in 77 normal weight non-insulin-dependent diabetic (NIDD) and 72 age-, sex-, and weight-matched control individuals. In diabetic subjects with mild fasting hyperglycemia (<140 mg/dL) hepatic glucose production (1.85 ± 0.03 mg/kg · min) was similar to controls (1.84 ± 0.02); the major factor responsible for the elevated basal glucose level in the diabetic group was a decreased efficiency in the tissue uptake of glucose, as reflected by a 30% decline in the rate of glucose clearance (1.56 ± 0.03 v 2.00 ± 0.03 mL/kg · min, P < .001). In contrast, in diabetic subjects with fasting plasma glucose concentrations above 140 mg/dL, basal hepatic glucose production was significantly elevated (2.42 ± 0.08 mg/kg · min, P < .001) and correlated closely with the increase in fasting plasma glucose concentration (r = .796, P < .001). The basal rate of whole body glucose clearance reached a plateau value at fasting glucose levels of 160 to 180 mg/dL and did not contribute to the further rise in fasting plasma glucose concentrations above 160 to 180 mg/dL. Decreased efficiency of tissue glucose uptake is responsible the development of fasting hyperglycemia in patients with mild NIDDM (fasting plasma glucose < 140 mg/dL). As the diabetic state worsens, an increase in basal hepatic glucose production is the major factor responsible for the progressive rise in fasting glucose levels.
AB - The factors responsible for fasting hyperglycemia were investigated in 77 normal weight non-insulin-dependent diabetic (NIDD) and 72 age-, sex-, and weight-matched control individuals. In diabetic subjects with mild fasting hyperglycemia (<140 mg/dL) hepatic glucose production (1.85 ± 0.03 mg/kg · min) was similar to controls (1.84 ± 0.02); the major factor responsible for the elevated basal glucose level in the diabetic group was a decreased efficiency in the tissue uptake of glucose, as reflected by a 30% decline in the rate of glucose clearance (1.56 ± 0.03 v 2.00 ± 0.03 mL/kg · min, P < .001). In contrast, in diabetic subjects with fasting plasma glucose concentrations above 140 mg/dL, basal hepatic glucose production was significantly elevated (2.42 ± 0.08 mg/kg · min, P < .001) and correlated closely with the increase in fasting plasma glucose concentration (r = .796, P < .001). The basal rate of whole body glucose clearance reached a plateau value at fasting glucose levels of 160 to 180 mg/dL and did not contribute to the further rise in fasting plasma glucose concentrations above 160 to 180 mg/dL. Decreased efficiency of tissue glucose uptake is responsible the development of fasting hyperglycemia in patients with mild NIDDM (fasting plasma glucose < 140 mg/dL). As the diabetic state worsens, an increase in basal hepatic glucose production is the major factor responsible for the progressive rise in fasting glucose levels.
UR - http://www.scopus.com/inward/record.url?scp=0024507794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024507794&partnerID=8YFLogxK
U2 - 10.1016/0026-0495(89)90129-7
DO - 10.1016/0026-0495(89)90129-7
M3 - Article
C2 - 2657323
AN - SCOPUS:0024507794
SN - 0026-0495
VL - 38
SP - 387
EP - 395
JO - Metabolism
JF - Metabolism
IS - 4
ER -